124281-65-8Relevant articles and documents
RECEPTORS FOR URIC ACIDS. 2. A CAUTIONARY OBSERVATION
Kelly, T. Ross,Bilodeau, Mark T.,Bridger, Gary J.,Zhao, Chen
, p. 2485 - 2488 (1989)
Receptor 4 was designed to exceed the already high affinity of 1 for 2.Synthesis of 4 and its binding with 2 are described.
HEPATITIS B CORE PROTEIN MODULATORS
-
, (2018/04/13)
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound of formula:
Design of a fluorescent host for monitoring multiple hydrogen-bonding interaction directly by intramolecular charge-transfer emission
Araki, Koji,Tada, Ken-Ichi,Abe, Masanori,Mutai, Toshiki
, p. 1391 - 1396 (2007/10/03)
The hosts 2-dodecanamido-4-methyl-N-[4-(dimethylamino)phenyl]quinoline-7-carboxamide 1 and 2-dodecanamido-4-methyl-N-(4-methoxyphenyl)quinoline-7-carboxamide 2 bearing an aromatic amide unit exhibit an anomalous fluorescence with a large Stokes shift at a